WEXFORD, Pa. - Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP), known for its work in cell therapy for various diseases, has announced a significant rebranding to COEPTIS, signaling a strategic ...
In a remarkable display of market confidence, shares of COEP have surged to a 52-week high, reaching a price level of $13.58. According to InvestingPro analysis, the stock appears overvalued at ...